IIM
JAZZ icon

INTECH Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

INTECH Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.5M Buy
34,379
+15,587
+83% +$2.72M 0.06% 276
2025
Q4 		$3.19M Buy
18,792
+8,180
+77% +$1.25M 0.03% 523
2025
Q3 		$1.4M Sell
10,612
-5,475
-34% -$657K 0.01% 989
2025
Q2 		$1.71M Sell
16,087
-15,272
-49% -$1.66M 0.02% 866
2025
Q1 		$3.89M Buy
31,359
+138
+0.4% +$18K 0.04% 412
2024
Q4 		$3.84M Buy
31,221
+24,582
+370% +$2.9M 0.04% 416
2024
Q3 		$740K Sell
6,639
-5,880
-47% -$644K 0.01% 991
2024
Q2 		$1.34M Buy
+12,519
New +$1.38M 0.02% 551
2024
Q1 		– Sell
-6,429
Closed -$791K – 706
2023
Q4 		$791K Sell
6,429
-19
-0.3% -$2.37K 0.01% 467
2023
Q3 		$835K Sell
6,448
-3,739
-37% -$498K 0.01% 473
2023
Q2 		$1.26M Buy
10,187
+6,381
+168% +$859K 0.01% 427
2023
Q1 		$557K Sell
3,806
-201
-5% -$29.7K ﹤0.01% 599
2022
Q4 		$638K Buy
4,007
+201
+5% +$29.5K ﹤0.01% 581
2022
Q3 		$507K Hold
3,806
– – ﹤0.01% 590
2022
Q2 		$594K Buy
+3,806
New +$586K ﹤0.01% 589

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

INTECH Investment Management's JAZZ Position: Q1 2026 in Review

INTECH Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 83% in Q1 2026, buying an estimated $2.72M and bringing the position to 34,379 shares worth $6.5M. The position accounts for 0.06% of the portfolio, ranked #276.

INTECH Investment Management first reported a position in JAZZ in Q2 2022 and has held it in 15 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • INTECH Investment Management held 34,379 shares of Jazz Pharmaceuticals worth $6.5M as of Q1 2026.
  • INTECH Investment Management bought 15,587 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.72M.
  • Jazz Pharmaceuticals made up 0.06% of INTECH Investment Management's portfolio in Q1 2026, its #276 holding.
  • INTECH Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.